ZALGAMI (Class 5)
#3801421
Application Number:3801421
Status:
Protection Granted
Class:5
Applicant: Prothena Therapeutics Limited
Filing Date:Tue, 16 Jan 2018
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | ZALGAMI |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 3801421 |
| Nature/Scope of business | Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis. |
| Publication | In Journal No. 1849 |
| Status | Protection Granted |
| Applicant: | Prothena Therapeutics Limited |
| Applicant Address | Upper George's Street, Adelphi Plaza Dun Laoghaire Dublin A96T927 IE |
Frequently Asked Questions
What is the status of trademark ZALGAMI? ▾
The trademark application number 3801421 is currently marked as "Protection Granted" in the official trademark registry.
Who is the owner of trademark ZALGAMI? ▾
The trademark application number 3801421 is owned by Prothena Therapeutics Limited.
Which class does trademark ZALGAMI belong to? ▾
Trademark application number 3801421 is filed under Class 5, which relates to the specified goods and services.
Was trademark ZALGAMI published in the journal? ▾
Yes, trademark application number 3801421 was published in Journal No. 1849.
What is trademark ZALGAMI? ▾
Trademark application number 3801421 relates to "Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis.".
File Trademark at Just ₹1,999 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
10,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified